Last reviewed · How we verify
NCT02888392
The Effect of Zespri Green Kiwifruit on Digestive and Gut Health Functions
NA trial testing Kiwifruit in Irritable Bowel Syndrome in 60 participants. Completed in 30 January 2017.
30 January 2017
Quick facts
| Lead sponsor | Zespri International Limited |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 18 December 2015 |
| Primary completion | 30 January 2017 |
| Estimated completion | 30 January 2017 |
| Sites | 1 location across Italy |
Drugs / interventions tested
- Kiwifruit
- Psyllium
Conditions studied
- Irritable Bowel Syndrome — all drugs for Irritable Bowel Syndrome →
Sponsor
Zespri International Limited
Who can join
Adults 18 to 65, any sex, with Irritable Bowel Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The proposed study will primarily demonstrate the efficacy of kiwifruit as a food intervention for the relief of constipation and associated symptoms in functionally constipated adults, and those with IBS-C. Secondary measures will show the consumption of kiwifruit will result in improvements in gastro-intestinal discomfort levels of adults with IBS-C.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Consumption of 2 Green Kiwifruits Daily Improves Constipation and Abdominal Comfort-Results of an International Multicenter Randomized Controlled Trial.
Gearry R, Fukudo S, Barbara G, Kuhn-Sherlock B, et al · · 2023 · cited 28× · PMID 36537785 · DOI 10.14309/ajg.0000000000002124 -
UEG Week 2017 Oral Presentations
· 2017
Verify or expand the search:
- PubMed search for NCT02888392
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Kiwifruit
Trials testing the same drug.
- NCT05953324 — The Effects Of Kiwifruit Consumption On Sleep Quality, Fatigue And BMI Of Saudi Adults · NA · completed
- NCT03569527 — Kiwifruit, Prunes, & Fiber for Abdominal and Bowel Symptoms in US Patients With Chronic Constipation · NA · completed
- NCT03303417 — Effect of Kiwifruit on Gastrointestinal Fluid Distribution and Transit in Healthy Volunteers · NA · completed
Other recruiting trials for Irritable Bowel Syndrome
Currently open trials in the same condition.
- NCT07235228 — Effects of Vivatlac Synbiotic on Gut Micribiota of IBS Patients · NA · recruiting
- NCT07421011 — Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 · Phase 1 · recruiting
- NCT07360938 — Drug Interaction Potential of Pro-Inflammatory Conditions · recruiting
- NCT06788444 — Efficacy of Esketamine for Patients With Irritable Bowel Syndrome · NA · recruiting
- NCT07484412 — Efficacy and Safety of Encapsulated Bifidobacterium Longum BBH016 in Subjects With Lower Gastrointestinal Symptoms · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02888392 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Zespri International Limited
- Last refreshed: 2 July 2017
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02888392.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing